Technology

AddToAny

Google+ Facebook Twitter Twitter

New genomics centre to open

Cancer Research UK and AstraZeneca have announced that they are opening a new centre in the UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.

Cancer Research Shutterstock

This partnership will explore in more detail the function and interaction of genes and proteins in cancer, and apply new genome-altering technologies, such as CRISPR, to create sophisticated models of the disease for research.

The centre will be a dedicated world-class resource for AstraZeneca and Cancer Research UK’s academics and alliance partners working at all stages of translational research, from target discovery and validation, to assessing novel drug combinations.

discoverylabs.cancerresearchuk.org

Related Articles

Hens that lay human proteins in eggs offer future therapy hope

Chickens that are genetically modified to produce human proteins in their eggs can offer a cost-effective method of producing certain types of drugs, research suggests.

NHS to launch paid-for genomics tests

Healthy people in England will be able to pay the NHS to sequence their genes, on condition they share their data.

Biomarker for genome instability

Elevated levels of a protein called ubiquilin-4 can be a biomarker for genome instability, a Tel Aviv University study shows.

Combining optical, ultrasound technology

Researchers are developing a novel biomedical imaging system that combines optical and ultrasound technology to improve diagnosis of life-threatening diseases.

Top